EMA Application withdrawn: Vitragan (hyaluronidase) — ISTA Pharma Limited

View source ↗

Summary

The EMA withdrew the application for Vitragan (hyaluronidase) by ISTA Pharma Limited for vitreous hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitreous Hemorrhage

Drugs mentioned

• Vitragan

Snippet

Status: Application withdrawn. Therapeutic area: Vitreous Hemorrhage. MAH: ISTA Pharma Limited. Decision date: 31/12/2009